FindTrial
Sign In

To study effect of oral pregabalin in patients undergoing cabg for post operative pain management

Evaluation of Oral Pregabalin as Pre- Emptive Adjuvant on Post operative pain in patients undergoing coronary artery bypass grafting under general anaesthesia and high thoracic epidural : A randomized Control Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052308
Enrollment
64
Registered
2023-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: I257- Atherosclerosis of coronary arterybypass graft(s) and coronary artery of transplanted heart with angina pectoris

Interventions

Intervention1: Oral Pregabalin: Dose 150 mg preop,,75 mg pod 0 ,75 mg pod 1 Duration 3 days Route oral Control Intervention1: Oral b complex: To assess pain score and sedation score

Sponsors

Dr Dy Patil medical college and research centre Pimpri pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: With Ejection fraction more than 35% ASA 2&3, who can understand pain score and sedation score.

Exclusion criteria

Exclusion criteria: Not willing to participate, History of hyper sensitivity, suffering from Epilepsy, Liver disease, renal disease, psychiatric illness, ejection fraction less than 35.

Design outcomes

Primary

MeasureTime frame
To assess post operative pain, rescue analgesia, sedation score, delusion.Timepoint: 12 hours,24 hours ,72 hours—

Secondary

MeasureTime frame
Pain Score sedation ScoreTimepoint: Day before surgery—

Countries

India

Contacts

Public ContactDr Vipul Sharma

dr.dypatil medical college, pimpri, pune, maharashtra.

cyesh16@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026